Pon Arunachalam Boopathi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pon Arunachalam Boopathi has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Amit Kumar Subudhi
King Abdullah University of Science and Technology
8 shared publications - Sheetal Middha
Department of Medicine, S.P. Medical College, Bikaner, Rajasthan, India
7 shared publications - Dhanpat Kumar Kochar
Rajasthan University of Health Sciences, Jaipur, Rajasthan, India
6 shared publications - Jyoti Acharya
Department of Medicine, S.P. Medical College, Bikaner, Rajasthan, India
6 shared publications - Sanjay Kumar Kochar
Department of Medicine, S.P. Medical College, Bikaner, Rajasthan, India
6 shared publications - Ashis Das
Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Rajasthan, India
5 shared publications
Latest Publications
- 1 December 2016
- Published by Elsevier in Acta Tropica
- Vol. 164, 438-447
Design, construction and validation of a Plasmodium vivax microarray for the transcriptome profiling of clinical isolates
- 1 December 2016
- Published by Elsevier in Acta Tropica
- Vol. 164, 438-447
Design, construction and validation of a Plasmodium vivax microarray for the transcriptome profiling of clinical isolates
- 1 May 2015
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 201 (1) , 31-46
Plasmodium falciparum complicated malaria: Modulation and connectivity between exportome and variant surface antigen gene families
- 1 May 2015
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 201 (1) , 31-46
Plasmodium falciparum complicated malaria: Modulation and connectivity between exportome and variant surface antigen gene families
- Open Access
- 1 December 2014
- Published by Elsevier in Genomics Data
- Vol. 2, 393-395
An in vivo transcriptome data set of natural antisense transcripts from Plasmodium falciparum clinical isolates
- 1 December 2014
- Published by Elsevier in Genomics Data
- Vol. 2, 393-395
Open AccessAn in vivo transcriptome data set of natural antisense transcripts from Plasmodium falciparum clinical isolates
- Open Access
- 1 December 2014
- Published by Elsevier in Genomics Data
- Vol. 2, 199-201
Dataset of natural antisense transcripts in P. vivax clinical isolates derived using custom designed strand-specific microarray
- 1 December 2014
- Published by Elsevier in Genomics Data
- Vol. 2, 199-201
Open AccessDataset of natural antisense transcripts in P. vivax clinical isolates derived using custom designed strand-specific microarray
- 1 June 2014
- Published by Elsevier in Experimental Parasitology
- Vol. 141, 39-54
Natural antisense transcripts in Plasmodium falciparum isolates from patients with complicated malaria
- 1 June 2014
- Published by Elsevier in Experimental Parasitology
- Vol. 141, 39-54
Natural antisense transcripts in Plasmodium falciparum isolates from patients with complicated malaria
- 1 December 2013
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 20, 428-443
Revealing natural antisense transcripts from Plasmodium vivax isolates: Evidence of genome regulation in complicated malaria
- 1 December 2013
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 20, 428-443
Revealing natural antisense transcripts from Plasmodium vivax isolates: Evidence of genome regulation in complicated malaria
- 27 September 2010
- Published by Taylor & Francis in Platelets
- Vol. 21 (8) , 623-627
Thrombocytopenia inPlasmodium falciparum,Plasmodium vivaxand mixed infection malaria: A study from Bikaner (Northwestern India)
The occurrence, relation and magnitude of thrombocytopenia in different species of malaria are not clearly defined. This study included 1,064 patients admitted with malaria to study thrombocytopenia (platelet count Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) mono infection and mixed infection (Pf + Pv). The species diagnosis was done by peripheral blood film (PBF) and rapid diagnostic test (RDT). Validation by polymerase chain reaction (PCR) was done only in patients with severe thrombocytopenia (platelet count Pf, 460 (43.23%) Pv and 79 (7.42%) mixed malaria (Pf + Pv). Thrombocytopenia was observed in 24.6% (262/1064) patients. The risk was greatest in the mixed infections in comparison to monoinfection individually (43.04% [34/79]; mixed vs Pv monoinfection: Odds Ratio [OR] = 1.675 [95% Confidence Interval (CI) 1.029–2.726], p < 0.0366; mixed vs Pf monoinfection: OR=3.911 [95% CI 2.367–6.463], p < 0.0001). Pv monoinfection (31.09% [143/460]) had greater risk compared to Pf monoinfection (16.19% [85/525]; OR = 2.335 [95% CI 1.722–3.167], p < 0.0001). The occurrence of severe thrombocytopenia was also higher in Pv monoinfection (18.18% [26/143]) in comparison to either Pf monoinfection (10.59% [9/85], OR = 1.877 (95% CI 0.834–4.223)) or mixed infection (11.76% [4/34]; OR = 1.667 (95% CI 0.540–5.142) but this association was statistically not significant. Six patients (3 Pv, 2 Pf and 1 mixed) developed severe epistaxis requiring platelet transfusion. There was no relation between parasite density and platelet count as many patients with severe thrombocytopenia had parasite density similar to patients without thrombocytopenia. We found that the association of thrombocytopenia was statistically more significant with P. vivax monoinfection as compared to P. falciparum.
- 27 September 2010
- Published by Taylor & Francis in Platelets
- Vol. 21 (8) , 623-627
Thrombocytopenia inPlasmodium falciparum,Plasmodium vivaxand mixed infection malaria: A study from Bikaner (Northwestern India)
The occurrence, relation and magnitude of thrombocytopenia in different species of malaria are not clearly defined. This study included 1,064 patients admitted with malaria to study thrombocytopenia (platelet count Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) mono infection and mixed infection (Pf + Pv). The species diagnosis was done by peripheral blood film (PBF) and rapid diagnostic test (RDT). Validation by polymerase chain reaction (PCR) was done only in patients with severe thrombocytopenia (platelet count Pf, 460 (43.23%) Pv and 79 (7.42%) mixed malaria (Pf + Pv). Thrombocytopenia was observed in 24.6% (262/1064) patients. The risk was greatest in the mixed infections in comparison to monoinfection individually (43.04% [34/79]; mixed vs Pv monoinfection: Odds Ratio [OR] = 1.675 [95% Confidence Interval (CI) 1.029–2.726], p < 0.0366; mixed vs Pf monoinfection: OR=3.911 [95% CI 2.367–6.463], p < 0.0001). Pv monoinfection (31.09% [143/460]) had greater risk compared to Pf monoinfection (16.19% [85/525]; OR = 2.335 [95% CI 1.722–3.167], p < 0.0001). The occurrence of severe thrombocytopenia was also higher in Pv monoinfection (18.18% [26/143]) in comparison to either Pf monoinfection (10.59% [9/85], OR = 1.877 (95% CI 0.834–4.223)) or mixed infection (11.76% [4/34]; OR = 1.667 (95% CI 0.540–5.142) but this association was statistically not significant. Six patients (3 Pv, 2 Pf and 1 mixed) developed severe epistaxis requiring platelet transfusion. There was no relation between parasite density and platelet count as many patients with severe thrombocytopenia had parasite density similar to patients without thrombocytopenia. We found that the association of thrombocytopenia was statistically more significant with P. vivax monoinfection as compared to P. falciparum.